In Vivo Ready™ Anti-Human CD28 (CD28.6)
カートを見る または ショッピングを続ける
説明
The CD28.6 antibody reacts with human CD28, a 44 kDa type I surface glycoprotein which acts as a co-stimulatory receptor in support of the T cell receptor (TCR). CD28 exists as a homodimer with specificity for two known ligands, known as B7-1 (CD80) and B7-2 (CD86), which are expressed on activated B cells and antigen-presenting cells. These ligands trigger CD28 signaling in concert with TCR activation to drive T cell proliferation, induce high-level expression of IL-2, impart resistance to apoptosis, and enhance T cell cytotoxicity. The interaction / co-stimulatory signaling between ≥ ≥ ≥ the B7 ligands and CD28 provides crucial communication between ≥ ≥ ≥ T cells and B cells or APCs to coordinate the adaptive immune response. The CD28.6 antibody is reported to have neutralizing activity and is also useful for western blotting.
Name | In Vivo Ready™ Anti-Human CD28 (CD28.6) |
---|---|
Cat. No. | 40-0288 |
Data Sheets | TDS | SDS |
Alternative Names | T44 |
Gene ID | 940 |
Clone | CD28.6 |
Isotype | Mouse IgG2a, κ |
Reactivity | Human |
Cross Reactivity | Human |
Format | FITC |
Application | FC - Validated FA, WB - Reported in literature, not validated in house |
For Research Use Only. Not intended for use in diagnostic procedures.